CTLA4 and neoplasm: However, in chronic liver disease, this immune tolerance shifts toward a suppressive tumor microenvironment (TME), characterized by migration of regulatory T cells, myeloid-derived suppressor cells, tumor-associated macrophages, and increased expression of immune-checkpoint molecules such as PD-L1 and CTLA-4 [10,11,12].